Research & Outcomes | Hypertension, Asthma and Diabetes

With the initial success regarding diabetes, the program began to quickly extend to other disease states including the following conditions now currently actively managed under our disease management program which including:  hypertension, asthma, diabetes, back pain, hyperlipidemia, neck pain, depression, headache, congestive heart failure, liver disease, atrial fibrillation, osteoporosis, immune disorders, kidney failure and many more.

With the large number of patients studied in the areas of hypertension, diabetes and asthma, the following 3 studies and outcomes are usually of particular interest to employers.

  • Hypertension.  5 Year, 6200+ Patients.  Journal of American Pharmacy.
    • 53% decrease in risk of cardiovascular event.
    • 50%+ reduction in risk of related cardiovascular emergency department visit.
    • 31% reduction in medical costs related to cardiovascular patients.
    • View External Research Article.
  • Diabetes Study.  5 Year, 200 Patients, Journal of American Pharmacy.
    • Total direct medical cost decrease $1,200 to $1,872 per patient per year.
    • Estimated productivity increases estimated at $18,000 annually.
    • View External Research Article.
  • Asthma Study.  5 Year, 200+ Patients.  Journal of American Pharmacy.
    • Total direct medical cost decrease $725 per patient per year.
    • Indirect cost savings estimation of $1,230 per patient per year.
    • View External Research Article.